Seneschal Advisors’s Eli Lilly LLY Stock Holding History

Seneschal Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36K	Hold	30	–	–	0.02%	116
2026 Q1	$27.6K	Hold	30	–	–	0.02%	114
2025 Q4	$32.2K	Buy	30 +7	+30%	+$6.69K	0.02%	110
2025 Q3	$17.5K	Buy	+23	New	+$17.1K	0.01%	130

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Seneschal Advisors's LLY Position: Q2 2026 in Review

Seneschal Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 30 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #116.

Seneschal Advisors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Seneschal Advisors held 30 shares of Eli Lilly worth $36K as of Q2 2026.
Seneschal Advisors left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.02% of Seneschal Advisors's portfolio in Q2 2026, its #116 holding.
Seneschal Advisors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.